| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |